Total Payments
$1,169
2024 Payments
$386.60
Companies
16
Transactions
29
Medicare Patients
407
Medicare Billing
$16,500
Payment Breakdown by Category
Food & Beverage$998.61 (85.5%)
Education$169.98 (14.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $998.61 | 27 | 85.5% |
| Education | $169.98 | 2 | 14.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $287.16 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $285.76 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $130.15 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $101.77 | 4 | $0 (2024) |
| Incyte Corporation | $78.26 | 1 | $0 (2023) |
| Celgene Corporation | $50.96 | 2 | $0 (2024) |
| Genentech USA, Inc. | $41.49 | 2 | $0 (2024) |
| Menarini Silicon Biosystems, Inc. | $35.65 | 2 | $0 (2024) |
| Seagen Inc. | $32.00 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.12 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $386.60 | 14 | Janssen Biotech, Inc. ($99.99) |
| 2023 | $540.53 | 12 | Janssen Pharmaceuticals, Inc ($142.11) |
| 2022 | $118.34 | 2 | Janssen Biotech, Inc. ($96.41) |
| 2021 | $123.12 | 1 | Janssen Pharmaceuticals, Inc ($123.12) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
| 11/11/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.74 | General |
| Category: Hematology | ||||||
| 08/13/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Monoclonal Antibody | ||||||
| 06/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Immunology and Neurology | ||||||
| 03/25/2024 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: BioOncology | ||||||
| 03/11/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: HEMATOLOGY | ||||||
| 03/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2024 | Menarini Silicon Biosystems, Inc. | Cellsearch (Device) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Diagnostics | ||||||
| 01/24/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.22 | General |
| Category: Hematology | ||||||
| 12/08/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $69.99 | General |
| Category: Oncology | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $104.02 | General |
| 10/31/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Oncology | ||||||
| 10/13/2023 | MENARINI SILICON BIOSYSTEMS, INC. | Cellsearch (Device) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Diagnostics | ||||||
| 10/02/2023 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Oncology | ||||||
| 09/20/2023 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: BioOncology | ||||||
| 09/06/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Oncology | ||||||
| 06/21/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: ONCOLOGY | ||||||
| 03/29/2023 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $78.26 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 358 | 469 | $46,915 | $13,508 |
| 2022 | 3 | 49 | 50 | $14,350 | $2,992 |
Total Patients
407
Total Services
519
Medicare Billing
$16,500
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 132 | $33,000 | $9,317 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 17 | $5,950 | $1,607 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 108 | 142 | $2,840 | $1,168 | 41.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 111 | 151 | $3,775 | $1,126 | 29.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 27 | $1,350 | $289.65 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 15 | 15 | $5,250 | $1,169 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 21 | $5,250 | $1,035 | 19.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 14 | $3,850 | $788.03 | 20.5% |
About Michelle Schaefer, NP
Michelle Schaefer, NP is a Primary Care healthcare provider based in East Meadow, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1437507142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Schaefer, NP has received a total of $1,169 in payments from pharmaceutical and medical device companies, with $386.60 received in 2024. These payments were reported across 29 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($998.61).
As a Medicare-enrolled provider, Schaefer has provided services to 407 Medicare beneficiaries, totaling 519 services with total Medicare billing of $16,500. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location East Meadow, NY
- Active Since 06/03/2016
- Last Updated 06/03/2016
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1437507142
Products in Payments
- XARELTO (Drug) $287.16
- DARZALEX (Biological) $166.40
- KEYTRUDA (Biological) $101.77
- IMBRUVICA (Drug) $99.99
- MONJUVI (Drug) $78.26
- REBLOZYL (Biological) $50.96
- Phesgo (Biological) $41.49
- Cellsearch (Device) $35.65
- PADCEV (Biological) $32.00
- CALQUENCE (Drug) $26.13
- ALUNBRIG (Drug) $25.12
- Gamunex-C (Biological) $21.29
- TECVAYLI (Biological) $19.37
- IBRANCE (Drug) $18.93
- ZEJULA (Drug) $16.03
- Orserdu (Drug) $15.19
- Poteligeo (Drug) $15.01
- MONOFERRIC (Drug) $13.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.